TY - JOUR
T1 - Dentatorubral-pallidoluysian atrophy (DRPLA) with a small ganglioglioma component containing neurofibrillary tangles and polyglutamine aggregation
AU - Yamada, Seiji
AU - Yamazaki, Tatsuya
AU - Nakata, Satoshi
AU - Nobusawa, Sumihito
AU - Ikota, Hayato
AU - Ide, Munenori
AU - Mizushima, Kazuyuki
AU - Harigaya, Yasuo
AU - Hirato, Junko
AU - Yokoo, Hideaki
N1 - Publisher Copyright:
© 2017 Japanese Society of Neuropathology
PY - 2017/8
Y1 - 2017/8
N2 - Dentatorubral-pallidoluysian atrophy (DRPLA), one of the polyglutamine diseases, has not been reported in combination with ganglioglioma (GG). Herein, we report an autopsy case of a 72-year-old man with DRPLA with a small GG component harboring neurofibrillary tangles (NFTs) and polyglutamine aggregates. NFTs, cytoplasmic accumulations of hyper-phosphorylated tau, are mainly observed in Alzheimer's disease (AD) and other tau-associated neurodegenerative disorders. NFTs can also be present in normal aging, and are occasionally observed in low-grade central nervous system (CNS) neoplasms such as GG. In the present case, whole brain examination demonstrated widespread deposition of polyglutamine aggregates, including GG, whereas NFTs were restricted to the GG component. In addition, no other AD or aging-related neuropathological structures were detected throughout the CNS. These findings may provide us with clues to elucidate the pathogenetic mechanisms that neuronal neoplasms may have to develop NFTs regardless of aging, and that polyglutamine may accumulate in neoplastic neurons in polyglutamine disease.
AB - Dentatorubral-pallidoluysian atrophy (DRPLA), one of the polyglutamine diseases, has not been reported in combination with ganglioglioma (GG). Herein, we report an autopsy case of a 72-year-old man with DRPLA with a small GG component harboring neurofibrillary tangles (NFTs) and polyglutamine aggregates. NFTs, cytoplasmic accumulations of hyper-phosphorylated tau, are mainly observed in Alzheimer's disease (AD) and other tau-associated neurodegenerative disorders. NFTs can also be present in normal aging, and are occasionally observed in low-grade central nervous system (CNS) neoplasms such as GG. In the present case, whole brain examination demonstrated widespread deposition of polyglutamine aggregates, including GG, whereas NFTs were restricted to the GG component. In addition, no other AD or aging-related neuropathological structures were detected throughout the CNS. These findings may provide us with clues to elucidate the pathogenetic mechanisms that neuronal neoplasms may have to develop NFTs regardless of aging, and that polyglutamine may accumulate in neoplastic neurons in polyglutamine disease.
UR - http://www.scopus.com/inward/record.url?scp=85011573051&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85011573051&partnerID=8YFLogxK
U2 - 10.1111/neup.12365
DO - 10.1111/neup.12365
M3 - Article
C2 - 28144989
AN - SCOPUS:85011573051
SN - 0919-6544
VL - 37
SP - 335
EP - 340
JO - Neuropathology
JF - Neuropathology
IS - 4
ER -